Home
Fairmount Healthcare Fund II, Director: Apogee Therapeutics APGE Buy · Filed 23/07/17
Trade details
- Type
- Insider buy
- Amount
- $15,172,993
- Shares · price
- 892,529 sh · $17.00 a share
- Held after
- 892,529 sh
- Trade date
- 23/07/13
- Filed
- 23/07/17
- Days to filing
- 4 days
7 insiders bought this week
- Insiders buying this week
- 7 insiders
Apogee Therapeutics trades, last 26 weeks
What else happened in Apogee Therapeutics around then
Filed or reported within 30 days of the trade day · 23/06/13~23/08/12Fairmount Healthcare Fund II's recent trades
- Fairmount Healthcare Fund II
SellSpyre Therapeutics
SellSpyre Therapeutics
SYRE
$399.7M
4,684,781 sh
$399.7M
Filed 06/23
Traded 06/23
- Fairmount Healthcare Fund II
BuyViridian Therapeutics, Inc.\DE
BuyViridian Therapeutics, Inc.\DE
VRDN
$20M
1,176,470 sh
$20M
Filed 05/13
Traded 05/11
- Fairmount Healthcare Fund II
BuyZenas BioPharma
BuyZenas BioPharma
ZBIO
$3M
150,000 sh
$3M
Filed 04/01
Traded 03/31
- Fairmount Healthcare Fund II
SellApogee Therapeutics
SellApogee Therapeutics
APGE
$133.5M
1,750,000 sh
$133.5M
Filed 01/22
Traded 01/22
- Fairmount Healthcare Fund II
BuyCrescent Biopharma
BuyCrescent Biopharma
CBIO
$18.2M
1,360,000 sh
$18.2M
Filed 25/12/08
Traded 25/12/04
